Core Insights - The Ministry of Industry and Information Technology and the National Medical Products Administration announced the second batch of selected units for the innovative task of biomedical materials, with Suzhou securing 15 positions, representing 17.4% of the national total and 75% of Jiangsu Province's entries, highlighting Suzhou's strong innovation capabilities in the biomedical materials sector [1][2]. Group 1: Innovations in Biomedical Materials - Peijia Medical's micro-nano fiber composite material was selected, showcasing its uniqueness in the valve industry and addressing critical clinical challenges in heart valve applications [1][2]. - Peijia Medical's new polymer valve technology, which uses non-biological, inorganic materials, significantly reduces production costs and is expected to have a longer lifespan than current biological valves, potentially decreasing the need for repeat surgeries [2]. - Haiwang Medical's newly developed block polyether amide resin aims to break the reliance on imported medical polymer materials, targeting a market previously dominated by French companies, with a market size exceeding 10 billion [2]. Group 2: Support for New Material Development - Suzhou has implemented the "Guidance Directory for the First Batch of Key New Material Application Demonstration," providing recognition support and financial incentives to stimulate enterprise investment in key material research [3]. - The new materials industry has emerged as Suzhou's third trillion-level industrial cluster, following electronic information and equipment manufacturing [3].